- Dec 16, 2022
Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy
- Dec 15, 2022
Patient Education: Lenalidomide - Immunomodulatory Agents - IMIDS
- Dec 10, 2022
Patient Education: Bortezomib (Velcade) - Proteasome Inhibitor
- Dec 9, 2022
Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor
- Dec 6, 2022
Patient Education: Ciltacabtagene Autoleucel - Carvykti - (CART Cell Therapy) - Immunotherapy
- Dec 6, 2022
Patient Education: Idecabtagene Vicleucel (CART Cell Therapy) - Immunotherapy
- Dec 6, 2022
Patient Education: Isatuximab-irfc - Sarclisa - Monoclonal Antibody - Immunotherapy
- Dec 5, 2022
Patient Education: Pomalidomide (Pomalyst) Immunomodulatory Agents - IMIDS
- Dec 4, 2022
Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy
- Dec 4, 2022
Patient Education: Thalidomide (Thalomid) Immunomodulatory Agents - IMIDS
- Dec 3, 2022
Patient Education: Ixazomib (Ninlaro) - Proteasome Inhibitor
- Dec 2, 2022
Patient Education: Selinexor (Xpovio) - XPO1 inhibitor
- Dec 1, 2022
Patient Education: Dexamethasaone (Decadron) and other Steroids
- Dec 1, 2022
Patient Education: Belantamab Mafodotin-blmf (Blenrep) Antibody Drug Conjugate for Multiple Myeloma